drugset / Trial / NCT00005035

Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

NCT00005035 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who have advanced head and neck cancer.

Timeline

Start
1999-12
Primary completion
—
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule — Intravenous

Indications